| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.002 |